Literature DB >> 11800537

Drugs of abuse in pregnancy.

A Wright1, J Walker.   

Abstract

Care for the drug-using pregnant woman is being increasingly recognized as part of the obstetrician's role. There is great potential for improvement in provision of services for this group of women, partly because traditionally our antenatal clinics have not been perceived as being conducive to disclosure regarding drug use, but also because hard data and, indeed, randomized controlled trials on the subject, are scarce.From the little evidence available, and from our own experience in this area, we have attempted to outline the main problems encountered in the antenatal, intrapartum and postnatal periods with each of the main drugs of abuse and the management thereof. It is important to note that we include cigarette smoking and alcohol, probably the most commonly used drugs in pregnancy, and recognize that the picture is wider than the stereotypical emaciated intravenous heroin addict. Where possible, evidence from trial data is included, but much of the what is quoted is descriptive from personal experience from ourselves and others working in the field. Copyright 2001 Harcourt Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11800537     DOI: 10.1053/beog.2001.0242

Source DB:  PubMed          Journal:  Best Pract Res Clin Obstet Gynaecol        ISSN: 1521-6934            Impact factor:   5.237


  6 in total

1.  Refining Measurement of Substance Use Disorders Among Women of Child-Bearing Age Using Hospital Records: The Development of the Explicit-Mention Substance Abuse Need for Treatment in Women (EMSANT-W) Algorithm.

Authors:  Taletha Mae Derrington; Judith Bernstein; Candice Belanoff; Howard J Cabral; Hermik Babakhanlou-Chase; Hafsatou Diop; Stephen R Evans; Milton Kotelchuck
Journal:  Matern Child Health J       Date:  2015-10

2.  Barriers to receiving substance abuse treatment among rural pregnant women in Kentucky.

Authors:  Afton Jackson; Lisa Shannon
Journal:  Matern Child Health J       Date:  2012-12

3.  The Prevalence and Impact of Substance Use Disorder and Treatment on Maternal Obstetric Experiences and Birth Outcomes Among Singleton Deliveries in Massachusetts.

Authors:  Milton Kotelchuck; Erika R Cheng; Candice Belanoff; Howard J Cabral; Hermik Babakhanlou-Chase; Taletha M Derrington; Hafsatou Diop; Stephen R Evans; Judith Bernstein
Journal:  Matern Child Health J       Date:  2017-04

4.  Enhancement of tolerance development to morphine in rats prenatally exposed to morphine, methadone, and buprenorphine.

Authors:  Yao-Chang Chiang; Tsai-Wei Hung; Cynthia Wei-Sheng Lee; Jia-Ying Yan; Ing-Kang Ho
Journal:  J Biomed Sci       Date:  2010-06-07       Impact factor: 8.410

Review 5.  Pharmacologic interventions for pregnant women enrolled in alcohol treatment.

Authors:  Erica J Smith; Steve Lui; Mishka Terplan
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08

6.  The impact of cocaine and heroin on the placental transfer of methadone.

Authors:  Antoine Malek; Cristina Obrist; Silvana Wenzinger; Ursula von Mandach
Journal:  Reprod Biol Endocrinol       Date:  2009-06-11       Impact factor: 5.211

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.